SJ NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Scienjoy Holding Corp · Communication Services · Internet Content & Information

Open interactive chart View report data
Latest close 1.03 USD
26.6% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -8.3% below the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned 26.6%, after a 18.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 25d.

Setup score 42 out of 100
Latest Close 1.03 USD 31 Jul 2026
1W Return 26.6% latest completed week
4W Return 18.5% short-term follow-through
12W Return -6.5% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 26.6% Latest completed week; four-week move 18.5%. Indicator stack 21/33 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 47/100 32 relevant articles in the latest sentiment read. Event risk 25d Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.3% below the Trend Line and sits at 49.0% of its 52-week range. The latest completed week returned 26.6%, after a 18.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1812-week average 0.41

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 18.5% over four weeks, -6.5% over 12 weeks, and 29.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W26.6%
4W18.5%
12W-6.5%
26W-29.1%
52W29.5%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.99Latest activity-pressure read.
Pressure change9.6%Four-week change in activity pressure.
Leadership2.87Latest relative-leadership reading.
RS change116.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value44/100Relative valuation strength. Underlying universe rank 57; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
1.2x
Price divided by trailing earnings.
Price / sales
0.0x
Market value relative to trailing revenue.
EV / EBITDA
1.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
206.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
18.4%
Gross profit retained from each unit of revenue.
Operating margin
2.9%
Operating profit retained from revenue.
Free-cash-flow margin
5.7%
Free cash flow generated from revenue.
Return on invested capital
8.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-10.2%
Latest one-year revenue growth.
EPS growth
-29.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-10.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment47/100

Weighted news tone is neutral across 32 relevant articles.

6 positive · 18 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings25dNext report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-36.9%Distance below the 52-week high.
13-week volatility15.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+26.6%Week of 31 Jul.
Worst week-25.3%Week of 17 Jul.
Latest week+26.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks0
Modest losses6
Sharp losses9
Recent vol15.1%13-week weekly-return volatility.
Base vol13.4%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew11.2% / -8.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 5/12, activity pressure 0/12, relative leadership 5/12.

Activity pressure 0.18; No reversal markers Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 30; Buyback Yield rank 51 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment47/100

Weighted news tone is neutral across 32 relevant articles.

Scienjoy Holding Corp (SJ) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders50/100

No recent insider transaction evidence is stored.

 Earnings25d

Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.03 USD26.6%1.12 USD1.25 USD-0.992.87216.3KOff
24 Jul 20260.81 USD2.5%1.11 USD1.26 USD-1.24-18.24126.8KOff
17 Jul 20260.79 USD-25.3%1.11 USD1.28 USD-1.11-21.8738.0KOff
10 Jul 20261.06 USD22.2%1.10 USD1.29 USD-1.09-0.43274.3KOff
3 Jul 20260.87 USD-8.1%1.08 USD1.30 USD-1.10-17.19234.2KOff
26 Jun 20260.94 USD17.1%1.07 USD1.32 USD-0.89-9.51671.0KOff
19 Jun 20260.81 USD-13.1%1.07 USD1.33 USD-0.77-26.35204.7KOff
12 Jun 20260.93 USD-20.1%1.06 USD1.35 USD-0.40-13.74607.1KOn
5 Jun 20261.16 USD-1.7%1.05 USD1.36 USD-0.349.98311.7KOn
29 May 20261.18 USD-7.1%1.03 USD1.38 USD-0.446.63345.6KOn
22 May 20261.27 USD10.4%1.01 USD1.40 USD-0.5617.61588.1KOn
15 May 20261.15 USD4.5%0.98 USD1.42 USD-0.627.38321.7KOn
8 May 20261.10 USD-0.5%0.96 USD1.44 USD-0.582.1343.6KOn
1 May 20261.11 USD0.5%0.94 USD1.46 USD-0.277.9474.5KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.